source
- Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded marketNine midsize biopharma companies have agreed to voluntarily participate in the Trump administration's Most Favored Nation drug pricing program, adding to the 17 large pharmaceutical firms that prev…
- ARCH Venture Partners aims to raise $3 billion for its 14th biotech fundARCH Venture Partners, a leading biotech venture capital firm, announced its intention to raise about $3 billion for a new fund. The proposed fund would be the firm's 14th and would rank among the…